Selected research
Market Structure
Global Biochip Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Biochip Products market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Biochip Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Biochip Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Biochip Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Biochip Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Biochip Products include Illumina, Thermo Fisher Scientific, Cellix, GE Healthcare, Randox, BioDot, PerkinElmer, Roche and Horiba, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Biochip Products output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Biochip Products by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Biochip Products market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Biochip Products and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Biochip Products sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Biochip Products market size, projected growth trends, production technologies, key applications, and end-use industries.
Biochip Products Segment by Company
Illumina
Thermo Fisher Scientific
Cellix
GE Healthcare
Randox
BioDot
PerkinElmer
Roche
Horiba
Greiner Bio One International
Korea Materials & Analysis
Capitalbio
Dynamic Biosensors
Biochip Products Segment by Type
Active Chips
Passive Chips
Biochip Products Segment by Application
Medical
Life Science
Pharmaceutical
Agricultural
Other
Biochip Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biochip Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biochip Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biochip Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Biochip Products market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biochip Products industry.
Chapter 3: Detailed analysis of Biochip Products market competition landscape. Including Biochip Products manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Biochip Products by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Biochip Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Active Chips
- Passive Chips
Applications
- Medical
- Life Science
- Pharmaceutical
- Agricultural
- Other
Companies covered
- Illumina
- Thermo Fisher Scientific
- Cellix
- GE Healthcare
- Randox
- BioDot
- PerkinElmer
- Roche
- Horiba
- Greiner Bio One International
- Korea Materials & Analysis
- Capitalbio
- Dynamic Biosensors
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Biochip Products Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Biochip Products Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Biochip Products Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Biochip Products Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Biochip Products Market Dynamics
- 2.1 Biochip Products Industry Trends
- 2.2 Biochip Products Industry Drivers
- 2.3 Biochip Products Industry Opportunities and Challenges
- 2.4 Biochip Products Industry Restraints
3 Biochip Products Market by Manufacturers
- 3.1 Global Biochip Products Production Value by Manufacturers (2021-2026)
- 3.2 Global Biochip Products Production by Manufacturers (2021-2026)
- 3.3 Global Biochip Products Average Price by Manufacturers (2021-2026)
- 3.4 Global Biochip Products Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Biochip Products Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Biochip Products Manufacturers, Product Type & Application
- 3.7 Global Biochip Products Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Biochip Products Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Biochip Products Players Market Share by Production Value in 2025
- 3.8.3 2025 Biochip Products Tier 1, Tier 2, and Tier 3
4 Biochip Products Market by Type
- 4.1 Biochip Products Type Introduction
- 4.1.1 Active Chips
- 4.1.2 Passive Chips
- 4.2 Global Biochip Products Production by Type
- 4.2.1 Global Biochip Products Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Biochip Products Production by Type (2021-2032)
- 4.2.3 Global Biochip Products Production Market Share by Type (2021-2032)
- 4.3 Global Biochip Products Production Value by Type
- 4.3.1 Global Biochip Products Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Biochip Products Production Value by Type (2021-2032)
- 4.3.3 Global Biochip Products Production Value Market Share by Type (2021-2032)
5 Biochip Products Market by Application
- 5.1 Biochip Products Application Introduction
- 5.1.1 Medical
- 5.1.2 Life Science
- 5.1.3 Pharmaceutical
- 5.1.4 Agricultural
- 5.1.5 Other
- 5.2 Global Biochip Products Production by Application
- 5.2.1 Global Biochip Products Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Biochip Products Production by Application (2021-2032)
- 5.2.3 Global Biochip Products Production Market Share by Application (2021-2032)
- 5.3 Global Biochip Products Production Value by Application
- 5.3.1 Global Biochip Products Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Biochip Products Production Value by Application (2021-2032)
- 5.3.3 Global Biochip Products Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Illumina
- 6.1.1 Illumina Company Information
- 6.1.2 Illumina Business Overview
- 6.1.3 Illumina Biochip Products Production, Value and Gross Margin (2021-2026)
- 6.1.4 Illumina Biochip Products Product Portfolio
- 6.1.5 Illumina Recent Developments
- 6.2 Thermo Fisher Scientific
- 6.2.1 Thermo Fisher Scientific Company Information
- 6.2.2 Thermo Fisher Scientific Business Overview
- 6.2.3 Thermo Fisher Scientific Biochip Products Production, Value and Gross Margin (2021-2026)
- 6.2.4 Thermo Fisher Scientific Biochip Products Product Portfolio
- 6.2.5 Thermo Fisher Scientific Recent Developments
- 6.3 Cellix
- 6.3.1 Cellix Company Information
- 6.3.2 Cellix Business Overview
- 6.3.3 Cellix Biochip Products Production, Value and Gross Margin (2021-2026)
- 6.3.4 Cellix Biochip Products Product Portfolio
- 6.3.5 Cellix Recent Developments
- 6.4 GE Healthcare
- 6.4.1 GE Healthcare Company Information
- 6.4.2 GE Healthcare Business Overview
- 6.4.3 GE Healthcare Biochip Products Production, Value and Gross Margin (2021-2026)
- 6.4.4 GE Healthcare Biochip Products Product Portfolio
- 6.4.5 GE Healthcare Recent Developments
- 6.5 Randox
- 6.5.1 Randox Company Information
- 6.5.2 Randox Business Overview
- 6.5.3 Randox Biochip Products Production, Value and Gross Margin (2021-2026)
- 6.5.4 Randox Biochip Products Product Portfolio
- 6.5.5 Randox Recent Developments
- 6.6 BioDot
- 6.6.1 BioDot Company Information
- 6.6.2 BioDot Business Overview
- 6.6.3 BioDot Biochip Products Production, Value and Gross Margin (2021-2026)
- 6.6.4 BioDot Biochip Products Product Portfolio
- 6.6.5 BioDot Recent Developments
- 6.7 PerkinElmer
- 6.7.1 PerkinElmer Company Information
- 6.7.2 PerkinElmer Business Overview
- 6.7.3 PerkinElmer Biochip Products Production, Value and Gross Margin (2021-2026)
- 6.7.4 PerkinElmer Biochip Products Product Portfolio
- 6.7.5 PerkinElmer Recent Developments
- 6.8 Roche
- 6.8.1 Roche Company Information
- 6.8.2 Roche Business Overview
- 6.8.3 Roche Biochip Products Production, Value and Gross Margin (2021-2026)
- 6.8.4 Roche Biochip Products Product Portfolio
- 6.8.5 Roche Recent Developments
- 6.9 Horiba
- 6.9.1 Horiba Company Information
- 6.9.2 Horiba Business Overview
- 6.9.3 Horiba Biochip Products Production, Value and Gross Margin (2021-2026)
- 6.9.4 Horiba Biochip Products Product Portfolio
- 6.9.5 Horiba Recent Developments
- 6.10 Greiner Bio One International
- 6.10.1 Greiner Bio One International Company Information
- 6.10.2 Greiner Bio One International Business Overview
- 6.10.3 Greiner Bio One International Biochip Products Production, Value and Gross Margin (2021-2026)
- 6.10.4 Greiner Bio One International Biochip Products Product Portfolio
- 6.10.5 Greiner Bio One International Recent Developments
- 6.11 Korea Materials & Analysis
- 6.11.1 Korea Materials & Analysis Company Information
- 6.11.2 Korea Materials & Analysis Business Overview
- 6.11.3 Korea Materials & Analysis Biochip Products Production, Value and Gross Margin (2021-2026)
- 6.11.4 Korea Materials & Analysis Biochip Products Product Portfolio
- 6.11.5 Korea Materials & Analysis Recent Developments
- 6.12 Capitalbio
- 6.12.1 Capitalbio Company Information
- 6.12.2 Capitalbio Business Overview
- 6.12.3 Capitalbio Biochip Products Production, Value and Gross Margin (2021-2026)
- 6.12.4 Capitalbio Biochip Products Product Portfolio
- 6.12.5 Capitalbio Recent Developments
- 6.13 Dynamic Biosensors
- 6.13.1 Dynamic Biosensors Company Information
- 6.13.2 Dynamic Biosensors Business Overview
- 6.13.3 Dynamic Biosensors Biochip Products Production, Value and Gross Margin (2021-2026)
- 6.13.4 Dynamic Biosensors Biochip Products Product Portfolio
- 6.13.5 Dynamic Biosensors Recent Developments
7 Global Biochip Products Production by Region
- 7.1 Global Biochip Products Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Biochip Products Production by Region (2021-2032)
- 7.2.1 Global Biochip Products Production by Region (2021-2026)
- 7.2.2 Global Biochip Products Production Forecast by Region (2027-2032)
- 7.3 Global Biochip Products Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Biochip Products Production Value by Region (2021-2032)
- 7.4.1 Global Biochip Products Production Value by Region (2021-2026)
- 7.4.2 Global Biochip Products Production Value by Region (2027-2032)
- 7.5 Global Biochip Products Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Biochip Products Production Value (2021-2032)
- 7.6.2 Europe Biochip Products Production Value (2021-2032)
- 7.6.3 Asia-Pacific Biochip Products Production Value (2021-2032)
- 7.6.4 South America Biochip Products Production Value (2021-2032)
- 7.6.5 Middle East & Africa Biochip Products Production Value (2021-2032)
8 Global Biochip Products Consumption by Region
- 8.1 Global Biochip Products Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Biochip Products Consumption by Region (2021-2032)
- 8.2.1 Global Biochip Products Consumption by Region (2021-2026)
- 8.2.2 Global Biochip Products Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Biochip Products Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Biochip Products Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Biochip Products Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Biochip Products Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Biochip Products Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Biochip Products Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Biochip Products Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Biochip Products Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Biochip Products Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Biochip Products Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Biochip Products Value Chain Analysis
- 9.1.1 Biochip Products Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Biochip Products Production Mode & Process
- 9.2 Biochip Products Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Biochip Products Distributors
- 9.2.3 Biochip Products Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst